kurosbio.com // cs@kurosbio.com
1
Duan R, et al. Eur Cell Mater 2019;37:60-73. * In vitro or in vivo studies may not be predictive of clinical experience in humans.
†
MagnetOs is not cleared by FDA as an osteoinductive bone graft.
MagnetOs is a registered trademark of Kuros Biosciences.
PROMO/MAG/US/005-20/R00 05 Oct 2020.
are discovering how the power of osteoimmunology
can help eliminate non-unions
PIONEERING
SURGEONS
The interplay between our skeletal and immune systems is the fi eld of research known as osteoimmunology.
MagnetOs bone graft harnesses this interplay. Its unique submicron surface topography polarizes
macrophages to the pro-healing M2 phenotype. These, in turn, upregulate mesenchymal stem cells, leading
to bone formation instead of scar tissue.
1*
Bone forms, even in soft tissue, without the need for added cells or growth factors.
1*
†
NASS 2020
SEE THE PRESENTATION FROM DR. R. TODD ALLEN, MD, PHD
ENTITLED, IMMUNOMODULATION BY MAGNETOS BONE GRAFT
